R&D BIO 2024 - Live Coverage pharmaphorum is back at the BIO International Convention this year, coming to you from sunny San Diego with two days of live coverage of one of the year’s biggest pharma executive gathering
News Appeal finds NICE must reconsider Alzheimer's drugs Lilly and Eisai's bid to secure NHS coverage of their Alzheimer's therapies has entered a new phase, after an appeal of last year's rejection by NICE.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.